Kura Oncology, Inc.
KURA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422143
In the last 90 days, Kura Oncology, Inc. insiders filed 2 open-market purchases and 8 sales; 221 institutions reported holding it in 13F filings for Q2 2026, worth $953.1M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Kura Oncology, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 133 | 141 | +8 |
| Shares | 75.3M | 78.8M | +3.43M (+4.6%) |
| Value | $686.9M | $1.13B | +$445.6M (+64.9%) |
New holders (23)
Institutions that held Kura Oncology, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (15)
Institutions that held Kura Oncology, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Dark Forest Capital Management LP | 80,162 | $731.1K |
| Jump Financial, LLC | 49,614 | $452.5K |
| Thrivent Financial for Lutherans | 39,465 | $359.0K |
| Inspire Advisors, LLC | 37,698 | $343.8K |
| Graham Capital Management, L.P. | 21,131 | $192.7K |
| Corton Capital Inc. | 18,409 | $167.9K |
| Bayesian Capital Management, LP | 14,026 | $127.9K |
| Axq Capital, LP | 12,943 | $118.0K |
| E Fund Management Co., Ltd. | 11,929 | $109.0K |
| Gsa Capital Partners LLP | 11,039 | $101.0K |
| Denali Advisors LLC | 9,000 | $82.1K |
| CWM, LLC | 413 | $4.00K |
| Allspring Global Investments Holdings, LLC | 350 | $3.19K |
| GWM Advisors LLC | 215 | $1.96K |
| Glassman Wealth Services | 183 | $1.67K |